10 үр дүн
BACKGROUND OF THE INVENTION
The present invention is in the technical fields of biochemistry and medicine. More particularly, the present invention is in the technical field of cannabinoid and terpene biochemistry, supplementation, medicinal therapy and nutraceutical therapy.
Cannabis is known in
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of
FIELD OF THE INVENTION
The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of
RELATED APPLICATIONS
There are no previously filed, nor currently any co-pending applications, anywhere in the world.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is relevant to the field of suppressing sensory afferent neuron symptoms of itch and, more particularly,
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor.
BACKGROUND OF THE INVENTION
Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica
FIELD OF THE INVENTION
The following invention relates generally to the field of methods of chemical purification. More specifically, the present invention relates to a method of producing natural health or medicinal products from Cannabis species, for example, industrial hemp.
BACKGROUND OF THE
SUMMARY
The present invention relates to a product, e.g., compound, obtained from the hydrogenation of cannabis oil, compositions that include the product, and methods of preparing the product. Hydrogenation converts cannabinoids, as well as, terpenoids, flavonoids and sterols present in cannabis
FIELD OF THE INVENTION
The invention generally relates to hydrogenation of the essential oil of cannabis plants, including cannabis plant species Cannabis sativa, C. indica and C. ruderalis. The hydrogenation of the plant essential oil provides an enriched source of hexahydrocannabanoids for use in